Ebopiprant
Ebopiprant (OBE022) is a selective, orally active antagonist of the prostaglandin F2α receptor. It is used in research to investigate the role of PGF2α signaling in metabolic disorders, including obesity, with applications in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2005486-31-5
Product Name Alternative
Ebopiprant, OBE 022, OBE022, OBE-022, PGF2α
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.73% (May vary between batches)
Solubility
DMSO:100 mg/mL (166.74 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.67 mM)
Smiles
CC (C) [C@H] (N) C (=O) OCC[C@H] (NC (=O) [C@@H]1SCCN1S (=O) (=O) c1ccc (cc1) -c1ccccc1) c1ccc (F) cc1
Molecular Formula
C30H34FN3O5S2
Molecular Weight
599.74
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL703445V 500 µL Each
Cdca4 Rat shRNA Lentiviral Particle (Locus ID 500727)
Sign In for Pricing
View Details PC1002941-01 100 mg
3-Bromo-1- (4-fluorophenyl) -1H-pyrazole-5-carboxylic acid
Sign In for Pricing
View Details PC1002941-02 250 mg
3-Bromo-1- (4-fluorophenyl) -1H-pyrazole-5-carboxylic acid
Sign In for Pricing
View Details